Amneal Pharmaceuticals Overview
- Founded
- 2002
- Status
- Public
- Employees
- 6,000
- Stock Symbol
- AMRX
- Investments
- 15
- Share Price
- $4.95
- (As of Friday Closing)
Amneal Pharmaceuticals General Information
Description
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products and Specialty products. Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. It generates a majority of its revenue from the Generic business segment.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Drug Discovery
Stock Exchange
NYS
Primary Office
- 400 Crossing Boulevard
- 3rd Floor
- Bridgewater, NJ 08807
- United States
+1 (908) 000-0000
Amneal Pharmaceuticals Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.95 | $4.83 | $2.40 - $6.18 | $731M | 148M | 1.5M | $0.62 |
Amneal Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 3,413,788 | 3,413,788 | 3,443,817 | 4,846,406 |
| Revenue | 1,992,523 | 1,992,523 | 1,626,373 | 1,662,991 |
| EBITDA | 345,605 | 345,605 | 155,198 | 78,252 |
| Net Income | 91,059 | 91,059 | (361,917) | (169,726) |
| Total Assets | 4,006,033 | 4,006,033 | 3,665,890 | 4,352,736 |
| Total Debt | 2,943,126 | 2,943,126 | 2,769,936 | 2,691,396 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Amneal Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Amneal Pharmaceuticals‘s full profile, request access.
Request a free trialAmneal Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Produ
Pharmaceuticals
Bridgewater, NJ
6,000
As of 2020
00.000
000000 - 000
00.000
0000000
mco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volup
000000000000000
Trevose, PA
000
As of 0000
000000000
00000 00
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatu
000000000000000
Woodcliff Lake, NJ
000
As of 0000
00000
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAmneal Pharmaceuticals Competitors (22)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lannett Company | Corporation | Trevose, PA | 000 | 000000000 | ||
| 00000 000000000000 | Formerly VC-backed | Woodcliff Lake, NJ | 000 | 00000 | 00000000000 | 00000 |
| 0000 0000000000000 | Corporate Backed or Acquired | Haifa Bay, Israel | 0000 | 0000 | 00000000000 | |
| 00000 | Failed Transaction (M&A) | Hafnarfjordur, Iceland | 000 | 000000000000 | ||
| 000 00000000000000 | Formerly PE-Backed | Ramapo, NY | 0000 | 000.00 | 000000&0 | 000.00 |
Amneal Pharmaceuticals Executive Team (36)
Amneal Pharmaceuticals Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000000 0000 | Amneal Pharmaceuticals | Board Member | 000 0000 |
| 0. 00000 | Self | Board Member | 000 0000 |
| 0000 00000 | Amneal Pharmaceuticals | Co-Founder, Chairman and Managing Director | 000 0000 |
| 0000 0000000 | Self | Chairman & Board Member | 000 0000 |
| 000000 00000 | Self | Board Member | 000 0000 |
Amneal Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAmneal Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Amneal Pharmaceuticals‘s full profile, request access.
Request a free trialAmneal Pharmaceuticals Investments & Acquisitions (15)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000000 | 11-Jan-2021 | 000000000000000000 | 00000 | Drug Discovery | 000000 00000 |
| 000000 | 31-Jan-2020 | 000000000000000000 | 00000 | Pharmaceuticals | 000000 00000 |
| 000000 00000000000 | 07-May-2018 | 000000000000000000 | 00000 | Distributors (Healthcare) | |
| 00000 000000000000 | 04-May-2018 | 0000000000 | Pharmaceuticals | 000000 00000 | |
| Actavis Australia | 01-May-2015 | Merger/Acquisition | 00.000 | Pharmaceuticals | 000000 00000 |
Amneal Pharmaceuticals Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Gemini Laboratories | Distributors (Healthcare) | Bridgewater, NJ | 2013 |
| 000000 | Pharmaceuticals | Pulaski, TN | 0000 |
Amneal Pharmaceuticals Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 000000 | 01-Jun-2013 | 0000000000 | Completed |
|